gard steering committee report j bousquet, r dahl
DESCRIPTION
GARD Steering committee report J Bousquet, R Dahl. Steering committee report 1- Consequences for GARD of the publication of the WHO Chronic Disease report 2- GARD members 3- Modified TOR 4- Preparation of the Launch 5- "GARD manual" 6- Dissemination of GARD to countries. Step 2. Step 1. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/1.jpg)
GARD
Steering committee reportJ Bousquet, R Dahl
![Page 2: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/2.jpg)
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members3- Modified TOR
4- Preparation of the Launch5- "GARD manual"
6- Dissemination of GARD to countries
![Page 3: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/3.jpg)
GARD Stepwise approachMay 2005
GARD priorities
Integrated GARD action plan
Step 1Step 2
Step 3
2005 2006 2007 2008 2009 2010
Pilot studies in countries
GARD action plan in countries
![Page 4: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/4.jpg)
GARD priorities
Integrated GARD action plan
Step 1Step 2
Step 3
2005 2006 2007 2008 2009 2010
Pilot studies in countries
GARD action plan in countries
GARD Stepwise approachMarch 2006
![Page 5: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/5.jpg)
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report
![Page 6: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/6.jpg)
October 5, 2005
QuickTime™ et undécompresseur TIFF (LZW)
sont requis pour visionner cette image.
![Page 7: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/7.jpg)
Estimate population needs and advocate
WG.1- Burden, risk factors and surveillance (G Viegi, S Buist, Y Fukuchi)
WG.2- Awareness and advocacy (C Lenfant, A Turnbull, P van Cauwenberge)
![Page 8: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/8.jpg)
Formulate and adopt policyWG.3- Prevention and health promotion (M Boland, A
Custovic)
WG.4- Diagnosis of CRD (K Rabe, S Wenzel) WG.5- Control of CRD and allergies,
Availability and affordability of drugs (J Bousquet, E Bateman, L Fabbri, C van Weel)
WG.6- Pediatric asthma (C Baena-Cagnani, E Mantzouranis, FER Simons, E Valovirta)
![Page 9: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/9.jpg)
Formulate and adopt policyWG.3- Prevention and health promotion (M Boland, A
Custovic)
WG.4- Diagnosis of CRD (K Rabe, S Wenzel) and allergy (GW Canonica)
WG.5- Control of CRD and allergies, Availability and affordability of drugs
(J Bousquet, E Bateman, L Fabbri, C van Weel)
WG.6- Pediatric asthma (C Baena-Cagnani, E Mantzouranis, FER Simons, E Valovirta)
![Page 10: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/10.jpg)
Formulate and adopt policyWG.3- Prevention and health promotion (M Boland, A
Custovic)
WG.4- Diagnosis of CRD (K Rabe, S Wenzel) and allergy (GW Canonica)
WG.5- Control of CRD and allergies (J Bousquet, E Bateman, L Fabbri, C van Weel)
Availability and affordability of drugs (N Aït Khaled)
WG.6- Pediatric asthma (C Baena-Cagnani, E Mantzouranis, FER Simons, E Valovirta)
![Page 11: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/11.jpg)
In high income countries- patients can receive adequate diagnosis and treatment - but they are insufficiently diagnosed and treated- a disease-specific approach is needed- the goals of GARD are to better diagnose, treat and educate patients
In upper-middle income countries- few patients can receive adequate diagnosis and treatment the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in many places
In lower-middle and low income countries- very few patients can receive adequate diagnosis and treatment the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in most places
In all countries, health promotion and prevention are essential control by disease-specific approach control by syndromic approach no control
Current management of CRDCurrent management of CRD
![Page 12: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/12.jpg)
In high income countries- patients can receive adequate diagnosis and treatment - but they are insufficiently diagnosed and treated- a disease-specific approach is needed- the goals of GARD are to better diagnose, treat and educate patients
In upper-middle income countries- few patients can receive adequate diagnosis and treatment - the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in many places
In lower-middle and low income countries- very few patients can receive adequate diagnosis and treatment- the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in most places
In all countries, health promotion and prevention are essential control by disease-specific approach control by syndromic approach no control
GARD policyGARD policy
![Page 13: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/13.jpg)
Identify Policy Implementation Steps
National Coordination: • The GARD action plan should be applied at the country level • Establish national working groups with a national coordinator• The national coordination group will:
• Provide existing national statistics on CRD and allergies• Assess the specific needs for the given country • Review the GARD action plan • Determine the relevant issues for the country action plan • Develop a country-specific action plan
![Page 14: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/14.jpg)
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members
![Page 15: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/15.jpg)
WHO calls for a global and coordinated effortto fight chronic respiratory diseases
WE ARE GARD!
![Page 16: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/16.jpg)
GARD members
Governmental organizationsScientific societiesPatient's organizationsOther NGOs
Pharmaceutical industryGovernments
Year 1 Year 2
"Medical" Foundations
![Page 17: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/17.jpg)
GARD members
Governmental organizationsScientific societiesPatient's organizationsOther NGOs
Pharmaceutical industryGovernments
Year 1 Year 2
"Medical" Foundations
Targetted approachTargetted approach
![Page 18: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/18.jpg)
GARD members
Governmental organizationsScientific societiesPatient's organizationsOther NGOs
Pharmaceutical industryGovernments
Year 1 Year 2
World BankUnesco and others
Private sector
"Medical" Foundations
Foundations
![Page 19: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/19.jpg)
GARD members
Governmental organizationsScientific societiesPatient's organizationsOther NGOs
Pharmaceutical industryGovernments
Year 1 Year 2
World BankUnesco and others
Private sector
"Medical" Foundations
Foundations
Targetted approach firstTargetted approach first
Global approach laterGlobal approach later
![Page 20: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/20.jpg)
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members3- Modified TOR
![Page 21: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/21.jpg)
GARD TOR
• TOR december 2004: approved by members• Assembly meeting: revision of TOR NOT sent to WHO• to include private sector, WHO proposed a revised TOR (TOR2) (january 2006)• TOR2 should be discussed during the meeting and proposal sent to WHO
![Page 22: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/22.jpg)
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members3- Modified TOR
4- Preparation of the Launch
![Page 23: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/23.jpg)
Fact sheet
"Hundreds of millions of people suffer from chronic respiratory diseases worldwide, including:
o 300 million people with asthmao 62 million people with moderate to severe COPDo Millions of others with mild COPD, allergic rhinitis, and other chronic respiratory diseases, which are often undiagnosed."
![Page 24: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/24.jpg)
Chronic respiratory diseases asthma 300 millions GINA, 2004
Moderate to severe COPD 62 millions WHO, 2006Allergic rhinitis millions Secondary pulmonary hypertension Occupational CRD Chronic rhinosinusitis Post-infectious CRD Lung cancer and neoplasms of the respiratory organsSequellae of pulmonary embolism Cor pulmonale Sleep apnea syndrome Lung fibrosis
TOTAL: Hundreds of millions
![Page 25: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/25.jpg)
Chronic respiratory diseases asthma 300 millions GINA, 2004
COPD 150 millions Allergic rhinitis 400 millions Secondary pulmonary hypertension 25 millionsOccupational CRD 25 millionsChronic rhinosinusitis 50 millionsPost-infectious CRD No dataLung cancer and neoplasms of the respiratory organsSequellae of pulmonary embolism No dataCor pulmonale No dataSleep apnea syndrome 100 millionsLung fibrosis No data
TOTAL: > ONE BILLION
![Page 26: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/26.jpg)
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members3- Modified TOR
4- Preparation of the Launch5- "GARD manual"
![Page 27: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/27.jpg)
Geneva« pre-GARD »WHO meeting
GARDaccepted by WHO
1st GARDassembly
1st GARD/WHOmeeting
GARDmeeting
GARDLaunch
06-04 09-04 01-05 05-05 09-05 28-03-06
GARD GARD manualmanual
![Page 28: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/28.jpg)
Geneva« pre-GARD »WHO meeting
GARDaccepted by WHO
1st GARDassembly
1st GARD/WHOmeeting
GARDmeeting
GARDLaunch
06-04 09-04 01-05 05-05 09-05 28-03-06
GARD GARD manualmanual
GARD source document
Fact sheetsPress release
![Page 29: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/29.jpg)
Geneva« pre-GARD »WHO meeting
GARDaccepted by WHO
1st GARDassembly
1st GARD/WHOmeeting
GARDmeeting
GARDLaunch
06-04 09-04 01-05 05-05 09-05 28-03-06
GARD GARD manualmanual
GARD source document
Public Healthguide
Pocket guide
ReviewPublished by NGOs
Launch at ERS
![Page 30: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/30.jpg)
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members3- Modified TOR
4- Preparation of the Launch5- "GARD manual"
6- Dissemination of GARD to countries
![Page 31: GARD Steering committee report J Bousquet, R Dahl](https://reader035.vdocument.in/reader035/viewer/2022062323/56816093550346895dcfb807/html5/thumbnails/31.jpg)
Activities within countriesActivities within countries• ChinaChina: launch, Chinese Medical Association: launch, Chinese Medical Association• BrazilBrazil: Minister of Health (PAHO): Minister of Health (PAHO)• PolandPoland: Minister of Health: Minister of Health• IndiaIndia: President: President• Japan, Korea..Japan, Korea..: National coordination: National coordination• Cape Verde, Russia, TunisiaCape Verde, Russia, Tunisia: Pilot studies: Pilot studies